CHEMBL108

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvedBy 1976
true
gptkbp:ATCCode gptkb:C07AB03
gptkbp:bioavailability 50% (oral)
gptkbp:CASNumber gptkb:29122-68-7
gptkbp:category beta blocker
antianginal agent
antihypertensive agent
cardiovascular drug
gptkbp:contraindication asthma
severe bradycardia
cardiogenic shock
gptkbp:drug_type small molecule
gptkbp:eliminationHalfLife urine
6-7 hours
gptkbp:excretion renal
gptkbp:hasInChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
gptkbp:hasLogP 0.16
gptkbp:hasMolecularFormula C14H22N2O3
gptkbp:hasSMILES CC(C)NCC(CO)OC1=CC=C(C=C1)C(=O)N
https://www.w3.org/2000/01/rdf-schema#label CHEMBL108
gptkbp:indication myocardial infarction
hypertension
angina pectoris
gptkbp:IUPACName gptkb:4-[2-hydroxy-3-(propan-2-ylamino)propoxy]benzamide
gptkbp:KEGGID gptkb:D00222
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction beta-1 adrenergic receptor antagonist
gptkbp:meltingPoint 152-155°C
gptkbp:metabolism minimal hepatic
gptkbp:molecularWeight 266.34
gptkbp:name gptkb:Atenolol
gptkbp:origin synthetic
gptkbp:pKa 9.6
gptkbp:proteinBinding 6-16%
gptkbp:PubChem_CID gptkb:CHEMBL108
CHEBI:2269
DB00335
2249
gptkbp:routeOfAdministration oral
gptkbp:sideEffect dizziness
fatigue
bradycardia
cold extremities
gptkbp:synonym gptkb:Atenololum
gptkb:Tenormin
gptkbp:target beta-1 adrenergic receptor
gptkbp:UNII 50VV3VW0TI
gptkbp:bfsParent gptkb:Limonene
gptkb:carbamazepine
gptkbp:bfsLayer 6